Trial Profile
Effects of Glimepiride Monotherapy Versus Combined Neteglinide-Pioglitazone Therapy on Insulin Sensitivity in Type 2 Diabetic Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Glimepiride (Primary) ; Nateglinide (Primary) ; Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 13 Apr 2012 New trial record